
|Articles|February 15, 2007
B&L shows interest in corneal device
Rochester, NY-Bausch & Lomb has made an equity investment in-and secured an exclusive option to purchase-AcuFocus Inc., a developer of corneal inlay technology for treating presbyopia.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
2
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
3
The Residency Report: Cardiovascular risk scores as a window into ocular disease
4
Outlook Therapeutics resubmits BLA for bevacizumab-vikg (ONS-5010/LYTENAVA)
5





















